A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

JUNE Medical’s Galaxy II™ Used In Military Hospitals

JUNE Medical is proud to announce that it is supplying a U.S. military hospital with its award-winning Galaxy II self-retaining surgical retractor range, including the innovative Galaxy II LUX Connect light.

This is a great opportunity for JUNE to show its support to military and Veteran Affairs (VA) medical centers, by equipping them with the best-in-class surgical retractors.

The Galaxy II range was first used by world-class surgeons at Wilford Hall Ambulatory Surgical Center – the U.S. Air Force’s flagship medical facility in Texas – for an open inguinal hernia repair. The unique and adaptable design of the retractor, and the addition of the bifurcated light source, were invaluable for providing a clear visualization of cavities. The Galaxy II includes a novel CAM lock system that allows simple one-handed adjustments and reduces the number of staff required to assist, giving surgeons greater control over their surgical field. These same benefits can be applied to a variety of procedures, including ENT, colorectal, orthopedic, gynecologic, and other open surgeries. JUNE is hoping to expand this success across the 54 military hospitals and 152 VA facilities in the U.S., to provide serving soldiers, veterans, and their families with the highest quality surgical equipment.

Emanuel Adam, Director of Policy & Trade at BritishAmerican Business commented: “BAB is thrilled to witness yet another milestone in the growth journey of JUNE Medical, as this company continues to deliver life-changing British innovation to hospitals and surgeons across the United States. Today’s announcement is a fine example of how innovative businesses such as JUNE Medical are the backbone of the transatlantic trade and investment success story, to the benefit of patients and local communities across both countries.”

Laurie Spicer, International Trade Advisor at the Department for International Trade, commented: “I have not only had the pleasure of supporting June Medical with their launch in the USA but have been extremely impressed with their courage, commitment and dedication to delivering their award winning Galaxy retractor to U.S. medical facilities. They are an incredible team who work tirelessly to make sure they deliver an exceptional product with the best service at the best price.”

To learn more about the Galaxy II self-retaining retractor, visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.
“We are excited to present the first look at the safety and clinical activity of ELVN-001, which we believe supports the potential for ELVN-001 to address the limitations of the available active-site TKIs,” said Helen Collins, M.D., Chief Medical Officer of Enliven. “Across a wide dose range, ELVN-001 demonstrated activity in a heavily pre-treated patient population that includes post-asciminib patients, with a preliminary safety profile consistent with its highly selective design. Not only did all evaluable patients have improved or stable BCR::ABL1 transcript levels, but, importantly, 89% of all patients enrolled remain on study. We believe the initial data demonstrate the potential clinical utility of ELVN-001 for all types of patients, including those that are earlier in the treatment paradigm.”
The partnership is with Health-HavenRx ™, an online pharmacy platform. This partnership enables a new, convenient channel for patients to access POGO Automatic by using their health insurance on Intuity Medical’s e-commerce website at www.GoodtoPogo.com.

By using this website you agree to accept Medical Device News Magazine Privacy Policy